Record Details

Catalog Search

Search The Catalog



Repurposing therapeutic drugs for COVID-19 : research challenges and opportunities : hearing before the Subcommittee on Investigations and Oversight of the Committee on Science, Space, and Technology, House of Representatives, One Hundred Sixteenth Congress, second session, June 19, 2020.

Electronic resources

Record details

  • Physical Description: 1 online resource (iii, 75 pages) : illustration
  • Publisher: Washington : U.S. Government Publishing Office, 2021.

Content descriptions

General Note:
"Serial no. 116-74."
Access ID (govinfo): CHRG-116hhrg40634.
GPO Cataloging Record Distribution Program (CRDP).
Bibliography, etc. Note:
Includes bibliographical references.
Participant or Performer Note:
Hearing witnesses: Dr. Peter Lurie, President, Center for Science in the Public Interest; Dr. James Finigan, Director of the Respiratory Centers of Excellence, National Jewish Health; Dr. Rick L. Stevens, Associate Laboratory Director for Computing, Environment and Life Sciences, Argonne National Laboratory; Dr. Benjamin Rome, Associate Physician, Brigham and Women's Hospital; Postdoctoral Research Fellow, Harvard Medical School.
Date/Time and Place of an Event Note:
Date of hearing: 2020-06-19.
Source of Description Note:
Description based on online resource; title from PDF title page (govinfo, viewed Feb. 3, 2021).
Subject:
COVID-19 (Disease) > Treatment > United States.
COVID-19 (Disease) > United States.
Drugs > Research > United States.
Genre:
Legislative hearings.